TRDA NASDAQ
Entrada Therapeutics, Inc.
1W: -12.7%
1M: -26.3%
3M: -28.6%
YTD: -46.5%
1Y: -8.5%
3Y: -65.3%
$5.38
-0.30 (-5.28%)
Weekly Expected Move ±9.6%
$4
$5
$5
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — TRDA
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (17)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 54.4 | 63.1 | 62.5 | 60.0 | SEC ↗ |
| 2026-03-31 | 10-Q | 55.2 | 63.5 | 62.9 | 60.5 | SEC ↗ |
| 2025-09-30 | 10-Q | 57.9 | 63.6 | 62.7 | 61.4 | SEC ↗ |
| 2025-06-30 | 10-Q | 57.6 | 63.7 | 62.8 | 61.4 | SEC ↗ |
| 2025-03-31 | 10-Q | 57.1 | 62.8 | 62.4 | 60.7 | SEC ↗ |
| 2024-12-31 | 10-K | 59.6 | 64.1 | 63.9 | 62.6 | SEC ↗ |
| 2024-09-30 | 10-Q | 59.2 | 63.5 | 64.6 | 62.4 | SEC ↗ |
| 2024-06-30 | 10-Q | 59.1 | 63.7 | 64.9 | 62.6 | SEC ↗ |
| 2024-03-31 | 10-Q | 58.3 | 63.9 | 64.3 | 62.2 | SEC ↗ |
| 2023-12-31 | 10-K | 59.4 | 65.4 | 65.3 | 63.4 | SEC ↗ |
| 2023-09-30 | 10-Q | 59.6 | 64.9 | 65.1 | 63.2 | SEC ↗ |
| 2023-06-30 | 10-Q | 58.6 | 64.4 | 65.2 | 62.8 | SEC ↗ |
| 2023-03-31 | 10-Q | 61.4 | 65.9 | 65.2 | 64.2 | SEC ↗ |
| 2022-12-31 | 10-K | 62.4 | 66.7 | 66.5 | 65.2 | SEC ↗ |
| 2022-09-30 | 10-Q | 61.1 | 66.0 | 65.3 | 64.1 | SEC ↗ |
| 2022-06-30 | 10-Q | 61.0 | 65.9 | 64.5 | 63.8 | SEC ↗ |
| 2021-12-31 | 10-K | 60.9 | 66.3 | 65.7 | 64.3 | SEC ↗ |